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Cancer pain continues to be undertreated in up to half of cases, despite the availability of evidence-
based guidelines. This study aimed to: 
1. Identify barriers and facilitators to adult cancer pain assessment and management as 
perceived by Australian health professionals; 
2. Establish the perceived need for new Australian guidelines and implementation strategy; 
3. Identify which guidelines are used; 
4. Identify barriers and facilitators to guideline use. 
This article focuses on the perceptions of responding oncologists. 
Methods 
A cross-sectional survey was administered online. Invitations were circulated via peak bodies and 
clinical leaders. Comments were coded independently by two researchers. 
Results 
76 oncologists self-reported high concordance with evidence-based recommendations, except 
validated pain scales. Perceived barriers to pain management included insufficient non-
pharmacological interventions, access to and coordination between services, and time. Only 22% of 
respondents reported using pain guidelines. The Australian Therapeutic Guidelines - Palliative Care 
and US National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology – Adult 
Cancer Pain were the most widely used. Perceived barriers to guideline use included lack of access, 
awareness and any single standard. Respondents were generally supportive of new Australian 
guidelines and especially an implementation strategy. 
Conclusion 
Barriers to evidence-based practice and guideline use identified by our survey might be addressed 
via a clinical pathway that gives step-by-step guidance on evidence-based practice along with a 
framework for evaluation. Particular attention should be paid to promoting use of validated scales, 
patient education and non-pharmacological interventions, training of an appropriately skilled 
workforce, and improving care coordination. Challenges are discussed. 
KEY WORDS  






Pain is experienced by 30-75% of people with cancer and is under-treated in up to half of patients (1-
5). Research suggests that failure to manage pain is due to barriers at all levels (i.e. patient, 
caregiver, health professional and healthcare system) (6-17). Research suggests that implementation 
of evidence-based clinical practice guidelines for pain can improve the processes of care and patient 
outcomes (10). A systematic review identified three models that have demonstrated efficacy at least 
to some degree: institutional models, which provide policies and procedures for regular pain 
assessment and standardisation of pain treatment; clinical pathways, which provide step-by-step 
guidance on optimal sequencing and timing of assessment and management; and expert 
consultation. The reviewers concluded that a clinical pathway combined with a consultation model 
may be optimal for supporting the most important features of pain assessment and management, 
namely patient education, an interdisciplinary approach and continuity of care. 
 
In Australia, pain in people with cancer has been identified as an important area for improvement by 
both the National Institute of Clinical Studies (NICS) and the Cancer Institute New South Wales 
(NSW) (18, 19). The recently launched Australian National Pain Strategy has six major goals including, 
‘timely access to best-practice, evidence-based assessment and care’ (20).  The Pain Strategy was 
developed in 2010 at a National Pain Summit and included input from a Cancer Pain and Palliative 
Care Working Group. This Group concluded that a primary objective should be promotion of 
guidelines and systems to ensure adequate assessment and management of cancer pain. But more 
data are needed to guide selection of appropriate strategies. To date, Australian studies examining 
barriers to cancer pain assessment and management have focused on the perceptions of patients 
and caregivers (21-23). These surveys identified patient and caregiver barriers in the form of 
misconceptions about opioids, perceived lack of control, poor management expertise, and barriers 
to communication. A better understanding of barriers and facilitators from the perspectives of 
Australian health professionals is needed to inform promotion of evidence-based practice. 
 
The aims of the current study were to: 
1. Inform understanding of barriers and facilitators to adult cancer pain assessment and 
management in various Australian clinical practice settings from the perspectives of 
different disciplines; 
2. Establish the level of support for new Australian guidelines and associated 
implementation strategy; 
3. Find out which guidelines for adult cancer pain are used by different disciplines in 




4. Inform understanding of barriers and facilitators to adult cancer pain guideline use in 
order to develop a strategy for improving evidence-based practice. 
 
We were especially interested in the views of motivated clinicians most likely to drive change (24).   
Methods 
Design 
This study used a cross-sectional online survey design.  
Participants 
Participants were eligible if they self-identified as a health professional involved in caring for adults 
with cancer pain in Australia. This article focuses on responses from participants who self-reported 
their discipline as ‘medical oncologist’, ‘radiation oncologist’ or ‘surgical oncologist’. Oncologists play 
a pivotal role in the planning, delivery and coordination of cancer care. Understanding their current 
practice and attitudes is therefore critical for any efforts aimed at improving pain assessment and 
management. 
Participants were recruited via email invitations and newsletters sent out by peak bodies and other 
organisations (see Box 1 for those that circulated to oncologists). We also asked Australians clinical 
leaders in cancer pain to circulate the invitation via their networks. Clinical leaders were identified 
via the authors’ own networks and literature searches on Medline using Medical Subject Heading 
(MeSH) and keyword searches for ‘cancer’, ‘pain’ and ‘Australia’. 
Procedure 
An ‘open’ online survey was administered via a secure online platform, SurveyMonkey® 
(https://www.surveymonkey.com/). Open online surveys are subject to selection bias because 
participants self-select, leading to a ‘volunteer effect’. In the current study, an over-representation 
of motivated respondents with experience of, and interest in, guideline use seemed supportive of, 
rather than disabling to, our aims.  Given that uptake of guidelines is low unless specifically 
promoted, a more representative sample would likely have included only a small proportion of 
guideline users (10).  
Survey questions were developed by an expert panel comprising palliative care physicians, nurses, a 
medical oncologist and psycho-oncologist. A draft of the survey was circulated for review and 
comment by staff and postgraduate students at the University of Technology Sydney’s (UTS) Faculty 
of Nursing, Midwifery and Health. The study was approved as ‘low risk’ by UTS’s Human Research 
Ethics Committee. The survey ‘went live’ on 30th August 2011 and closed on 30th April 2012. 
Information about respondents requested in the final version of the survey included discipline and 
primary workplace location (state/territory, postcode), sector and outreach status. Respondents 
were asked how routinely their primary workplace implemented each of a list of evidence-based 
practices identified by Dy et al (2008) (25) and the Clinical Indicators for Pain Project funded by the 




and pain services; use of and familiarity with guidelines for assessment and management of cancer 
pain; the need for new Australian guidelines and implementation strategies; and perceptions of 
barriers and facilitators to best practice and use of guidelines. 
Item response options included yes/no, verbal rating scales (e.g. ‘strongly agree’, ‘agree’, ‘disagree’, 
‘strongly disagree’) and comment boxes after every item. Comments were independently coded by 
two authors (TL, AG) who then met to reach consensus.  
Results 
Seventy-six oncologists were recruited to the survey. Of these, 48 were medical oncologists, 24 
radiation oncologists andfour surgical oncologists; one respondent self-identified as both a medical 
oncologist and hematologist. The samples included four respondents who self-identified as 
registrars, nine as both oncologists and palliative care physicians, one as both a medical oncologist 
and pediatric oncologist, and one as both a medical oncologist and pediatric cancer pain specialist. 
The geographic spread of respondents roughly corresponded to that of the general population (27), 
with all states and territories represented except the Australian Capital Territory (ACT) (see Table 1). 
The Australian Health Practitioner Regulation Agency’s (AHPRA) annual report indicated that there 
were 421 medical oncologists and 316 radiation oncologists registered nationwide in 2010-2011 
(28). However, membership of professional bodies may more accurately reflect the numbers 
currently practising. Membership of the Medical Oncology Group of Australia (MOGA) in early 2012 
was 312, suggesting our response rate for this discipline might be around 15% (29). No data could be 
sourced on the number of surgical oncologists practising in Australia. 
 
Table 1 about here. 
Current practice in cancer pain assessment and management 
In general, respondents (N=72) indicated high levels of implementation of evidence-based standards 
for cancer pain assessment and management, the exceptions being use of a validated pain scale and 
routine patient education which were reportedly implemented ‘most of the time’ or ‘always or 
nearly always’ at only 43% and 64% of primary workplaces respectively. Barriers to assessment and 
management identified by around three-quarters or more (N=69) included difficulty accessing 
services to enable non-pharmacological management (88%), impact of distance on ability to access 
pain-related services (80%), lack of coordination across multiple providers (78%) and difficulty 
accessing interventional pain services (74%). The most commonly endorsed facilitators for improving 
assessment and management (N=75) was increase in dedicated clinician time (57%) and more 
patient education (51%), which were alone in being endorsed by half or more of respondents. Lack 
of time was also the most commonly identified barrier in comments, followed by lack of support 
from specialist pain and palliative care and community services. Responses from each discipline are 
summarised in Table 2. 




Of 69 respondents, 67% agreed that most patients with cancer pain would benefit from referral to a 
specialist palliative care (SPC); the corresponding figure for specialist pain service was 23%. SPC was 
also considered quicker and easier to access, with 74% reporting this to be acceptable compared 
with 51% for specialist pain services. Where access was less than acceptable, long waiting times 
were commonly cited as a barrier for both kinds of specialist service, while patient barriers and lack 
of availability were identified as important barriers for SPC and pain services respectively. Responses 
relating to SPC are summarised in Table 3 and specialist pain services in Table 4. 
Table 3 about here. 
Table 4 about here. 
Guideline use 
More than 80% of 73 respondents agreed there to be a need for new Australian guidelines on cancer 
pain assessment, pharmacological management and non-pharmacological management, as well as 
an implementation strategy to inform guideline use in and across different service settings. The 
latter received the most support, with several respondents leaving comments suggesting that efforts 
be focused on implementation of existing guidelines rather than development of new ones. Specific 
topics most frequently considered useful (N=69) were advice on best practice for specific cases of 
cancer pain (e.g. nociceptive) and inclusion of key performance indicators (95% each) and guidance 
on assessing patient-identified priorities and inclusion of patient 'action plans' to aid self-
management (90% each). 
Only 22% (N=17) of respondents reported that a guideline for cancer pain was routinely used in their 
primary workplace. The Therapeutic Guideline - Palliative Care was the most widely used (56%), 
followed by various institutional guidelines (31%) and the National Comprehensive Cancer Network 
(NCCN) (2010): Clinical practice guidelines in oncology - adult cancer pain (19%). These were also the 
guidelines most familiar to respondents who did not use a guideline. 
Of 14 guideline users, the majority agreed that one or more guideline was working well, that clinical 
staff adhered to the same pain guideline(s) and that use of pain guideline(s) influenced patient 
outcomes. Barriers to guideline use identified by respondents in comments included lack of 
awareness and access to guidelines and lack of a single standard. Several people commented that 
initiatives aimed at improving implementation were more needed than new guidelines but left no 
specific advice about what such initiatives should involve. 
Responses on guideline use from each discipline are summarised in Table 5. 
Table 5 about here. 
Discussion 
Responses from oncologists to our online survey provide complex new insights for supporting 
evidence-based practice in cancer pain in Australia. As in studies conducted in other countries (6-17), 
respondents identified barriers to cancer pain assessment and management at the levels of patient, 




suggested for overcoming such barriers received majority support. Similarly, whilst nearly 90% of 
respondents supported implementation of guidelines for cancer pain in general, less than a quarter 
reported using pain guidelines themselves. We interpret these conflicting results as follows.  
Barriers and facilitators to cancer pain assessment and management 
The high levels of evidence-based practice self-reported by respondents supports the supposition 
that this sample was more proactive regarding pain assessment and management than most (2, 3, 
10). The only evidence-based recommendation not routinely implemented in half or more 
workplaces was use of a validated pain scale. At first glance, this finding seems consistent with 
perceptions from other countries that inadequate assessment is the most common barrier to 
effective pain management (14, 16). However, over 90% of our respondents reported that pain 
assessment was routine in their primary workplaces, presumably through means other than scales in 
half of cases. Research suggests that health professionals often consider clinical evaluation to be 
superior to standardized scales in capturing the complexity of individual patient experience (30, 31). 
Future initiatives should therefore aim to convince cancer specialists that (while no substitute for in-
depth, individualized assessment) validated pain scales provide a useful means of screening and 
evaluating progress over time (32). Given evidence of poorer management of pain in ethnic 
minorities (4), routine screening via a validated pain scale also guarantees equitable assessment; 
translated versions may be especially useful where patients are migrants and do not speak the 
language of their host country.  
Several of the most commonly identified barriers to assessment and management of cancer pain on 
our survey concerned health care organization and resource issues. As well as lack of access due to 
distance or low capacity, perceived barriers related to poor coordination/ integration and limitations 
in the services available. Lack of coordination between services and communication between health 
professionals are barriers raised by both clinicians and consumers in the international qualitative 
literature (33). A clinical pathway that gives precise instructions on how to implement evidence-
based care along with a framework for evaluation has potential to address this problem by 
specifying roles and processes for interdisciplinary approaches to pain management and continuity 
of care (10). Importantly, this may enhance capacity at centres where specialist expertise is lacking. 
Respondents’ willingness to refer patients with cancer pain to SPC is reassuring given concerns 
among Australian palliative care professionals that referrals may be delayed by misconceptions that 
SPC is appropriate only at the end of life (34). It is also consistent with data from other Australian 
survey studies where oncologists identified symptom control as the most common reason they 
referred to SPC (35) and acknowledged the importance of concurrent models of care (36). 
Respondents’ recognition of the need for greater use of non-pharmacological strategies for cancer 
pain is consistent with consumer needs expressed in qualitative research (33). In addition to this 
being the most frequently cited barrier to pain management, several respondents commented on 
the need for greater support from allied health and psychology, for which funding in Australian 
cancer centres and reimbursement in community care is inconsistent. Pain is a symptom with 
complex biobehavioural influences and implications that should be assessed and managed 
holistically (37). Some contemporary guidelines include recommendations for non-pharmacological 




strategies available, cognitive-behavioural therapy (CBT) probably has the most substantial evidence 
base (38).  
Of particular concern among barriers identified is lack of time for cancer pain management. 
Evidence from the international literature suggests that oncologists today generally consider 
symptom management to be a core responsibility (39), so it seems likely that workforce shortages in 
Australian oncology (40) are responsible rather than lack of priority. This interpretation – together 
with the motivated character of our sample - is supported by the fact that most responses to the 
survey occurred during night-time hours. A clinical pathway has potential to address lack of time by 
improving efficiency and easing the burden of care on any individual discipline (10).  
Barriers identified in relation to opioid misconceptions among patients, caregivers and staff have 
been widely documented in both the international (17) and Australian (21) literatures, with 
corresponding calls for related educational strategies. Australia’s NPS Better Choices > Better Health 
(formerly known as the National Prescribing Service) employs facilitators to deliver unbiased, 
evidence-based information to health professionals in the workforce. Best-practice prescription for 
cancer pain would be a welcome future focus. 
It is interesting to note that most of the strategies we listed for improving cancer pain management 
were endorsed by less than half of respondents, including evidence-based approaches such as 
patient education (14, 41), clinician training aimed at addressing established shortfalls in knowledge 
(10, 42) and the change management standard of ‘clinical champions’ (24). These findings may 
reflect a ‘ceiling effect’ regarding current practice in pain management at respondents’ primary 
workplaces, at least as perceived by respondents themselves. The lack of support for training is 
especially interesting within the context of recent surveys from the United States (US) where cancer 
care specialists identified content to be limited on pain and palliative care more generally (16, 42). 
Data are currently lacking on the degree to which cancer pain is covered in Australian medical 
schools and residencies. A review of programs taught and the extent to which these are compulsory 
would establish whether pain is receiving due attention as a core competency.  
Guideline use 
The low usage of guidelines reported by this volunteer sample supports the Australian Cancer Pain 
and Palliative Care Working Group’s conclusion that guidelines have not been widely adopted. 
Interestingly, this occurred within the context of widespread support for new Australian guidelines 
and especially an implementation strategy to inform use within and across different service settings. 
These findings, coupled with the high levels of evidence-based practice, suggest that respondents 
may have been supporting new guidelines and implementation strategy for health professionals 
they perceived to be less competent than themselves. 
It is of interest here to note recent ‘perspectives’ published in the Medical Journal of Australia which 
highlight concerns of expert Australian health professionals that guidelines may inhibit critical 
reasoning and professional independence (43, 44). Whilst we too would defend the ‘art’ of medicine 
as practiced by expert clinicians, the evidence suggests that many cancer care professionals are not 
employing evidence-based practice for pain assessment and management (2, 3). Guidelines are not 




important steps in assessment and management are not omitted. It should be noted, also, that 
health professionals are not necessarily the best judges of their own expertise. A recent US survey 
found medical oncologists to report high levels of competency for managing cancer pain despite 
serious knowledge gaps identified by more objective assessment (16).  
A number of interventions have proven efficacy in changing clinician behavior and could be used to 
improve uptake of evidence-based practice. However, the magnitude of effect from any single 
intervention is likely to be small, and flow-on effects on clinical outcomes have been difficult to 
demonstrate. A recent systematic review identified the most effective interventions for improving 
quality and safety in healthcare to be clinician-directed audit and feedback cycles, clinical decision 
support systems, specialty outreach programs, chronic disease management programs, continuing 
professional education based on interactive small-group case discussions, and patient-mediated 
clinician reminders (45). Intervention attributes associated with success in promoting uptake of 
guidelines more specifically included adaptation to local needs, dissemination via an active 
educational intervention, presentation in easy-to-access/easy-to-use portable formats and 
implementation using patient-specific reminders. These findings underscore the need to take a 
concrete, personalised approach to convincing clinicians of the contribution that guidelines can 
make via a multifaceted approach using techniques that are active rather than passive in the 
demands they make (e.g. problem-based versus didactic learning) (46). 
Unfortunately, evidence for interventions using the above approaches to promote evidence-based 
practice in pain is limited. Two studies have demonstrated efficacy of clinical audit and feedback for 
improving nurse adherence to cancer pain guidelines (47, 48). Audit data at a unit level can also be 
used to provide persuasive evidence for changing processes and systems as well as building a 
business case for appropriate resources. In non-cancer pain management, two studies have provided 
evidence for decision support at the point of care, including one that used electronic administration 
to  incorporate patient-specific information to improve opioid therapy (49, 50). The prevalence of 
smart-phone and tablet technologies offer new opportunities for point of care electronic decision 
support via devices that are better suited to unobtrusive use outside the consulting room (51).  
Finally, guidelines for change management emphasize the need to involve stakeholders at each site 
to enhance ownership and tailor implementation to local needs and resources (24). For optimal 
effectiveness, then, any attempt at an Australian clinical pathway should be accompanied by tools 
for promoting and monitoring uptake and ongoing support within each institution. 
Limitations 
As already indicated, the most important limitation of this study is that our sample is unlikely to be 
representative of Australian oncologists more generally. We accepted the likelihood of a volunteer 
effect on the grounds that we were primarily interested in the views of motivated clinicians likely to 
drive change. In hindsight, it would have been useful to have asked respondents more explicitly 
about their willingness to be involved in improving practice via the strategies outlined above. 
Respondent numbers for each discipline were small, particularly for surgical oncologists. This 
prohibited meaningful comparison between responses from different disciplines. Data from a 
further, representative sample would be useful to contextualize our findings within the perceptions 




change practice. Data from hematologists are also needed to supplement those from oncologists 
described here. 
A further limitation relates to the self-reported and ad hoc nature of our survey for which we have 
no evidence of validity and reliability beyond face and content validation by an expert team. While 
the self-reported nature of our data means that reports of practice cannot be verified, questions 
were concerned with the frequency of evidence-based practice rather than more subjective self-
evaluation of practice quality. The likelihood that respondents answered items according to socially 
acceptability was reduced by the survey’s anonymity. However, the limited support respondents 
gave to benchmarks and measures for evaluating pain management may reflect a reluctance to 
advocate practices that would subject their services to greater scrutiny.  
Conclusion 
Barriers to cancer pain assessment and management identified by Australian oncologists in our 
survey might be addressed by a range of strategies including implementation of a national clinical 
pathway tailored to individual service settings and increased access to non-pharmacological 
approaches. Particular attention should be paid to promoting use of validated rating scales in 
assessment, patient education and non-pharmacological interventions, and improving coordination 
between different disciplines and services. Further research with representative samples is needed 
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Box 1. Organizations that circulated electronic invitations to oncologists to complete the survey 
 
Australasian Lung Cancer Trials Group (ALTG) 
Australia and New Zealand Breast Cancer Trials Group (ANZBCTG)  
Australia New Zealand Gynaecological Oncology Group (ANZGOG) 
Australian and New Zealand Melanoma Trials Group (ANZMTG) 
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) 
Australasian Sarcoma Study Group (ASSG) 
Cancer Services Networks National Demonstration Program (CanNET) Northern Territory 
Clinical Oncological Society of Australia (COSA) 
Cooperative Trials Group for Neuro-Oncology (COGNO) 
Medical Oncology Group of Australia (MOGA) 
Primary Care Collaborative Cancer Clinical Trials Group (PC4) 
Royal Australasian and New Zealand College of Radiologists – Radiation Oncology Section 
(RANZCR) 





Table 1. Sample characteristics 
State/territory 













NSW (32.3) 33 33 0 31 
VIC (24.9) 25 17 100 25 
QLD (20.2) 19 25 0 20 
SA (7.3) 10 4 0 6 
WA (10.4) 8 0 0 6 
TAS (2.3) 4 8 0 5 
NT (1.0) 0 8 0 3 
ACT (1.6) 0 0 0 0 
Sector     
Public practice 60 65 50 61 
Private practice 10 10 25 23 
Public hospital 29 25 25 14 
Outreach clinic     
Yes 31 35 50 32 








Table 2. Responses to questions on current practice in assessment and management of cancer pain 
Question (Response) Discipline 
How routinely does each of these practices takes place at 
















Use of breakthrough opioids in cancer patients receiving long-
acting opioids  100 95 100 
99 
Use of bowel regimens in cancer patients receiving opioids  98 91 100 96 
Regular pain assessment in cancer patients  98 91 100 96 
Routine assessment of pain in new cancer patients  93 86 100 91 
Scheduled pain medication for severe pain  91 86 100 90 
Follow-up of pain management for cancer patients  93 86 50 88 
Continuity of opioid doses across health care settings  83 77 100 82 
Routine pain education for cancer patients  67 59 50 64 
Use of a validated pain scale to assess cancer pain  50 32 25 43 
How much of a barrier is each of the following at your 
















Difficulty accessing services that enable non-pharmacological 
management of cancer pain 84 95 100 
88 
Impact of distance on ability to access pain-related services 
for patients 77 82 100 
80 
Lack of coordination across multiple providers 74 86 75 78 
Difficulty accessing interventional pain services 74 73 75 74 
Lack of benchmarks to assess improvement in quality of pain 
management over time 60 77 75 
66 
Lack of regular case reviews to critically discuss and evaluate 
pain assessment and management 58 73 100 
65 
Difficulty keeping abreast of advances from research 58 73 75 64 
Challenges posed by comorbidities 49 91 75 64 
Inadequate remuneration for time spent (e.g. on 
multidisciplinary meetings) 67 59 50 
63 
Difficulty accessing transport services for patients requiring 
management for cancer pain 60 64 75 
62 
Inability to access ongoing data on pain and quality of life to 





Difficulty accessing acute pain services 58 68 25 59 
Limited expertise in the assessment and management of 
cancer pain  39 41 75 
42 
Difficulty accessing palliative care services 21 27 75 26 
What would improve cancer pain assessment and 
















Increase in dedicated clinician time 65 50 0 57 
More patient education 56 45 25 51 
More caregiver education 48 41 25 45 
More training and access to information on pain assessment 
and management 37 55 50 
43 
A more multidisciplinary approach 35 55 25 41 
One or more clinical champion(s) 35 32 25 33 
New mechanisms for evaluating outcomes 9 5 0 7 
Unsure 4 9 25 7 
Policy changes 4 5 0 4 
†Evidence-based standards for cancer pain assessment and management called for by Dy et al (2008) (25) 




Table 3. Responses to questions regarding specialist PALLIATIVE CARE service involvement in cancer pain 
assessment and management 
















What proportion of patients with cancer pain would benefit 
from referral to a specialist PALLIATIVE CARE service for 
assessment and management? (Most/all or nearly all) 
70 59 75 67 
In your area health service, how quickly and easily can a 
specialist PALLIATIVE CARE service typically be accessed for 
assessment and management of cancer pain? (Access is of 
acceptable speed and ease) 
74 77 50 74 
How often is referral to a specialist PALLIATIVE CARE service 
for assessment and management of cancer pain delayed for 
















Delays are due to patients themselves (e.g. because they fear 
perceived side effects or addictiveness of treatment) 18 50 0 
23 
Long waiting time 18 25 0 17 
Difficulty accessing patient transport 0 50 0 12 
Difficult/complex referral processes 9 0 0 6 
Difficulty selecting which patients should be referred 0 25 0 6 
Lack of coordination between services 0 25 0 6 
Need for patients to travel to tertiary centres 0 25 0 6 
Lack of available specialist services 0 0 0 0 







Table 4. Responses to questions regarding specialist PAIN service involvement in cancer pain assessment 
and management 
 
















What proportion of patients with cancer pain would benefit 
from referral to a specialist PAIN service for assessment and 
management? (Most/all or nearly all) 
21 27 25 23 
In your area health service, how quickly and easily can a 
specialist PAIN service typically be accessed for assessment 
and management of cancer pain? (Access is of acceptable 
speed and ease) 
56 45 25 51 
How often is referral to a specialist PAIN service for 
assessment and management of cancer pain delayed for the 
















Long waiting time 50 60 0 48 
Lack of available specialist services 44 40 25 41 
Lack of coordination between services 25 30 0 24 
Need for patients to travel to tertiary centres 12 30 25 20 
Difficult/complex referral processes 2 30 0 11 
Difficulty accessing patient transport 0 30 0 10 
Delays are due to patients themselves (e.g. because they fear 
perceived side effects or addictiveness of treatment) 0 20 0 
7 
Lack of knowledge of available services 1 0 0 1 





Table 5. Responses to questions on guidelines for assessing and managing cancer pain 
Question (Response) Discipline 
What level of need do you think there is for the following? 















Implementation strategy to inform use of existing guidelines 
in and across different service settings  89 87 100 
89 
An Australian guideline for pharmacological management of 
cancer pain  89 87 50 
86 
An Australian guideline for non-pharmacological management 
of cancer pain  85 87 50 
84 
An Australian guideline for assessing cancer pain  85 78 75 82 
In a new Australian implementation strategy for guidelines 
















Advice on best practice for specific cases of cancer pain (e.g. 
nociceptive) 95 95 100 
95 
Inclusion of key performance indicators 60 82 50 95 
Guidance on assessing patient-identified priorities 88 95 100 91 
Inclusion of patient 'action plans' to aid self-management 91 91 100 91 
Patient version of implementation strategy 81 91 75 84 
Templates for taking case histories and identifying patient-
identified priorities 77 91 75 
81 
Guidance on roles for each discipline  74 86 75 78 















Yes 29 12 0 22 
















(Australian) Palliative Care Expert Group (2010): Therapeutic 
guidelines - Palliative Care. Version 3 64 0 NA 
56 
Institutional or departmental guideline(s) 36 0 NA 31 
National Comprehensive Cancer Network (2010): Clinical 
practice guidelines in Oncology - adult cancer pain 7 100 NA 
19 
American Society of Anaesthesiology (2006): Practice 
guidelines for cancer pain management - a report by the 
American Anaesthesiology task force on pain management, 




cancer pain section 
National Institutes of Health (2002): Symptom management 
in cancer: pain, depression and fatigue 0 50 NA 
6 
NHMRC Acute Pain Guidelines 7 0 NA 6 
European Society for Medical Oncology (2007): Minimum 
clinical recommendations for the management of cancer pain 
 
7 0 NA 
0 















One or more guideline working well 92 100 NA 93 
Clinical staff at my primary workplace adhere to the same 
pain guideline(s)  83 50 NA 
78 
Use of pain guideline(s) at my primary workplace influence(s) 
patient outcomes  67 100 NA 
72 
There are adequate resources at my primary workplace to 
provide care according to one or more pain guideline(s)  33 100 NA 
43 
My service endorses use of one or more particular pain 
guideline(s)  33 100 NA 
43 
 
†Respondents were asked to select from guidelines identified via a systematic review by Pigni et al. (2010) 
(50) and to specify any additional guidelines used. The following guidelines have been omitted from the 
table because no respondents used them: American Geriatrics Society (2002): The management of 
persistent pain in older persons; American Pain Society (2005): Guidelines for the management of cancer 
pain in adults and children; European Association for Palliative Care (2001): Morphine and alternative 
opioids in cancer pain; the EAPC recommendations; Joint Commission on Accreditation of Healthcare 
Organisations (2001): Pain - current understanding of assessment, management and treatments; MD 
Anderson Cancer Center (2003): Cancer pain; National Health and Medical Research Council (NHMRC) 
(2006): Guidelines for a palliative approach in residential aged care;  National Institutes of Health (2002): 
Symptom management in cancer: pain, depression and fatigue; Quality Improvement Scotland (2004): The 
management of pain in patients with cancer; Scottish Intercollegiate Guidelines Network (2008): Control of 
pain in patients with cancer; Singapore Ministry of Health (2003): Cancer pain; Texas Council (2005): 
Guidelines for treatment of cancer pain; American Geriatrics Society (2002): The management of persistent 
pain in older persons. 
 
 
 
 
